Back
Structure Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
32
GPCR
Structure Therapeutics
Last Price:
33.44
Seasonality Move:
-14.82%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Structure Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.62 | Sell |
| 20-day SMA: | 36.75 | Sell |
| 50-day SMA: | 38.81 | Sell |
| 200-day SMA: | 39.76 | Sell |
| 8-day EMA: | 33.58 | Sell |
| 20-day EMA: | 35.75 | Sell |
| 50-day EMA: | 37.61 | Sell |
| 200-day EMA: | 39.17 | Sell |
Structure Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.86 | Sell |
| Relative Strength Index (14 RSI): | 41.58 | Sell |
| Chaikin Money Flow: | 882035 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.2 - 39.9) | Sell |
| Bollinger Bands (100): | (35.54 - 41.32) | Sell |
Structure Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Structure Therapeutics Stock
Is Structure Therapeutics Stock a Buy?
- Structure Therapeutics share price is 33.41 while GPCR 8-day simple moving average is 33.62, which is a Sell signal.
- The stock price of GPCR is 33.41 while Structure Therapeutics 20-day SMA is 36.75, which makes it a Sell.
- Structure Therapeutics 50-day simple moving average is 38.81 while GPCR share price is 33.41, making it a Sell technically.
- GPCR stock price is 33.41 and Structure Therapeutics 200-day simple moving average is 39.76, creating a Sell signal.
GPCR Technical Analysis vs Fundamental Analysis
Sell
32
Structure Therapeutics (GPCR)
is a Sell
Is Structure Therapeutics a Buy or a Sell?
-
Structure Therapeutics stock is rated a Sell
The current Structure Therapeutics [GPCR] share price is $33.41. The Score for GPCR is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Structure Therapeutics Stock Info
Market Cap:
1.91B
Price in USD:
33.41
Share Volume:
1.21M
Structure Therapeutics 52-Week Range
52-Week High:
66.38
52-Week Low:
26.61
Sell
32
Structure Therapeutics (GPCR)
is a Sell
Structure Therapeutics Share Price Forecast
-
What is the Structure Therapeutics stock price today?
The Structure Therapeutics stock price is 33.41 USD today. -
Will GPCR stock go up or go down?
Structure Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Structure Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Structure Therapeutics is overvalued.
Is Structure Therapeutics Stock a Buy?
- Structure Therapeutics share price is 33.41 while GPCR 8-day exponential moving average is 33.58, which is a Sell signal.
- The stock price of GPCR is 33.41 while Structure Therapeutics 20-day EMA is 35.75, which makes it a Sell.
- Structure Therapeutics 50-day exponential moving average is 37.61 while GPCR share price is 33.41, making it a Sell technically.
- GPCR stock price is 33.41 and Structure Therapeutics 200-day simple moving average is 39.17, creating a Sell signal.
Fundamental Analysis of Structure Therapeutics
Is Structure Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.15 per share.
Technical Analysis of Structure Therapeutics
Should I short Structure Therapeutics stock?
- GPCR Moving Average Covergence Divergence (MACD) indicator is -1.86, suggesting Structure Therapeutics is a Sell
- Structure Therapeutics Relative Strength Index (RSI) is 41.58, which suggest Structure Therapeutics is oversold
- The Bollinger Bands (25) for Structure Therapeutics is (34.2 - 39.9), which suggest Structure Therapeutics is a Sell
- The Bollinger Bands (100) for Structure Therapeutics is (35.54 - 41.32), which suggest Structure Therapeutics is a Sell
* Structure Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.